CoChat

High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum Malaria

ter Kuile, F. O., Nosten, F., Thieren, M., Luxemburger, C., Edstein, M. D., Chongsuphajaisiddhi, T., Phaipun, L., Webster, H. K., White, N. J. · 1992 · Journal of Infectious Diseases
Cited by 110

The DOI matches its Crossref record.

Abstract

The therapeutic efficacy and toxicity of a high-dose (25 mg/kg) mefloquine regimen (M25) and the currently recommended regimen of 15 mg/kg (M15) were compared in 199 patients with acute falciparum malaria in an area with deteriorating multidrug resistance on the Thai-Burmese border. The clinical and parasitologic responses were significantly more rapid with M25. The incidence of treatment failures by day 7-9 was 7% for M15 and 1% for M25 (P = .03) and had increased to 40% and 9%, respectively, by day 28 (P < .0001). Overall failure rates were highest in children (P = .02). Parasite clearance times were a good predictor of the therapeutic response; all patients with parasitemia persisting > 5 days after treatment experienced subsequent recrudescence. Side effects were dose-related and included dizziness, anorexia, nausea, vomiting, and fatigue. Although vomiting < 1 h after treatment was more likely in young children, children overall tolerated mefloquine better than adults, and men better than women. The optimum treatment dose of mefloquine in this area is 25 mg/kg.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/infdis/166.6.1393

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 110

Metadata

Authors
ter Kuile, F. O., Nosten, F., Thieren, M., Luxemburger, C., Edstein, M. D., Chongsuphajaisiddhi, T., Phaipun, L., Webster, H. K., & White, N. J.
Venue
Journal of Infectious Diseases
Published
1992-12-01
Volume
166
Issue
6
Pages
1393-1400
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2005816578
Cited by
110
References
0
FWCI
12.21
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum Malaria. https://app.cochat.ai/papers/10.1093/infdis/166.6.1393
The paper
ter Kuile, F. O., Nosten, F., Thieren, M., Luxemburger, C., Edstein, M. D., Chongsuphajaisiddhi, T., Phaipun, L., Webster, H. K., & White, N. J. (1992). High-Dose Mefloquine in the Treatment of Multidrug-Resistant Falciparum Malaria. Journal of Infectious Diseases. https://doi.org/10.1093/infdis/166.6.1393

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.